Bristol Myers Squibb vs Insmed
Bristol Myers Squibb (BMY) and Insmed (INSM) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $120B
- Last close
- $58.80
- 12 months
- +28.0%
- Market value
- $31B
- Last close
- $141.33
- 12 months
- −29.2%
At a glance
- The biggest part of Bristol Myers Squibb's revenue is Growth Portfolio (55%); at Insmed it is ARIKAYCE (72%).
- Bristol Myers Squibb earns 69% of its revenue in the United States, Insmed 75%.
- By market value, Bristol Myers Squibb ($120.2B) is about 3.9 times Insmed ($31.0B).
- Over the last 12 months Bristol Myers Squibb's share price moved +28.0% and Insmed's −29.2%; against the S&P 500 that is +22.3 points and −34.9 points.
- In their last fiscal years Bristol Myers Squibb kept 14.6% of revenue as net income and Insmed -210.5%.
- In the last 90 days insiders reported 0 open-market purchases at Bristol Myers Squibb and 0 at Insmed; members of Congress disclosed 0 trades in Bristol Myers Squibb and 0 in Insmed.
- Next results: Bristol Myers Squibb Feb 3, 2027, Insmed Feb 17, 2027.
How each one makes money: Bristol Myers Squibb revenue · Insmed revenue
Share prices on one chart
Bristol Myers Squibb and Insmed, and up to three more you add, drawn on the same scale so you can see which moved more.
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Bristol Myers Squibb BMYNYSE · Pharmaceuticals | Insmed INSMNASDAQ · Pharmaceutical Preparations | |
|---|---|---|
| Size and profitability | ||
| Market value | $120B | $31B |
| Revenue, last fiscal year | $48.2B | $606M |
| Net income, last fiscal year | $7.05B | −$1.28B |
| Net marginNet income as a share of revenue | 14.6% | -210.5% |
| Free cash flow | $12.8B | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Compare with another company
Bristol Myers Squibb against
Common questions
How is Bristol Myers Squibb different from Insmed?
Bristol Myers Squibb (BMY) is in Pharmaceuticals on NYSE, with $48.2B of revenue in its last fiscal year and a net margin of 14.6%. Insmed (INSM) is in Pharmaceutical Preparations on NASDAQ, with $606M of revenue in its last fiscal year and a net margin of -210.5%. The biggest part of Bristol Myers Squibb's revenue is Growth Portfolio (55%); at Insmed it is ARIKAYCE (72%). Bristol Myers Squibb earns 69% of its revenue in the United States, Insmed 75%. The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Bristol Myers Squibb and Insmed compare in size?
Bristol Myers Squibb has the larger market value: Bristol Myers Squibb $120B and Insmed $31B, at the last close.
Whose share price rose more over the last 12 months, BMY or INSM?
Over the last 12 months Bristol Myers Squibb moved +28.0% and Insmed −29.2%. Past price moves say nothing about the future.
Which has had more insider buying, Bristol Myers Squibb or Insmed?
Since 2006, Insmed insiders reported 81 open-market purchases against 47 for Bristol Myers Squibb. These are counts of what was filed, not a view on either stock.
Do members of Congress trade BMY or INSM?
In the last 12 months, members of Congress disclosed 8 trades in Bristol Myers Squibb (BMY) and 1 in Insmed (INSM).
When did insiders last buy BMY and INSM?
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Bristol Myers Squibb pageInsmed pageRare insider trades this weekAll comparisons
https://oqro.io/compare/bmy-vs-insm







